A prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline

作者: Olivier Mirguet , Jérôme Toum , Alexis Denis

DOI:

关键词:

摘要: The present invention relates to the compound (2R,2'R)-bis(((((tetrahydro-2H-pyran- 4-yl)oxy)carbonyl)oxy)methyl) 1,1'-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising same and use of for treatment diseases or disorders wherein depletion serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus osteoarthritis.

参考文章(9)
Stacy A. Gurevitz, Marvin J. Stone, Amyloidosis: Diagnosis and Treatment edited by Morie A. Gertz, MD, and S. Vincent Rajkumar, MD. Proceedings (Baylor University. Medical Center). ,vol. 25, pp. 166- 166 ,(2012) , 10.1080/08998280.2012.11928822
Aesop Cho, Recent Advances in Oral Prodrug Discovery Annual Reports in Medicinal Chemistry Volume 41. ,vol. 41, pp. 395- 407 ,(2006) , 10.1016/S0065-7743(06)41027-7
Dale Gordon Pfizer Global Res. Dev. Mcleod, Anthony Pfizer Global Res. Dev. Marfat, Beta-lactamase inhibitor prodrug ,(2003)
Roland Jakob-Roetne, Roger David Norcross, Cornelia Hertel, Torsten Hoffmann, D-proline derivatives ,(1998)
Alan Peter Lewis, Susannah Karen Ford, Tejinder Kaur Bhinder, Mark Brian Pepys, Volker Germaschewski, Antigen binding proteins specific for serum amyloid p component ,(2011)
Joerg Huwyler, Roland Jakob-Roetne, Sonia Maria Poli, Prodrugs to d-prolines ,(2002)
Toshiro Meiji Seika Kaisha Ltd. Sasaki, Hiromi Meiji Seika Kaisha Ltd. Takata, Toshiki Meiji Seika Kaisha Ltd. Fujita, Yuko Meiji Seika Kaisha Ltd. Kano, Takehiko Meiji Seika Kaisha Ltd. Sawabe, Hisashi Meiji Seika Kaisha Ltd. Suzuki, Nobuyoshi Meiji Seika Kaisha Ltd. Baba, Kazuhiro Meiji Seika Kaisha Ltd. Aihara, Takashi Meiji Seika Kaisha Ltd. Ando, Takahisa Meiji Seika Kaisha Ltd. Maruyama, 2-thioethenyl carbapenem derivative ,(2006)